Timing-dependent dasatinib priming attenuates MHC class I-mediated inhibition of NK cells and CAR-NK cells

Natural killer (NK) cells are promising candidates for adoptive immunotherapy, but their ex vivo expansion is often accompanied by reduced cellular fitness and functional heterogeneity. Here, we identified that dasatinib, an FDA-approved tyrosine kinase inhibitor, could improve the expansion and antitumor function of NK cells. While dasatinib treatment from the start of culture impaired NK cell expansion, the introduction of dasatinib after the early expansion phase improved NK cell yields and viability without compromising NK cell purity. Transcriptomic analysis showed that dasatinib priming suppressed inflammatory signaling pathways and reduced the expression of apoptosis-related genes. Both transcriptomic and phenotypic analyzes further demonstrated downregulation of inhibitory signaling components, including SHP-1 and killer cell immunoglobulin-like receptor (KIR) family members. In line with these molecular changes, dasatinib-primed NK cells displayed enhanced cytotoxicity against tumor cells expressing high levels of MHC class I, consistent with modulation of MHC class I-related inhibitory signaling. Moreover, dasatinib priming improved the antitumor activity of anti-CD19 CAR-NK cells and enhanced cytotoxicity against MHC class I-expressing CD19+ tumor cells. Collectively, these findings identify dasatinib priming as a simple and clinically applicable strategy to improve the function and antitumor efficacy of expanded NK cells and CAR-NK cells.

Authors

Institutions

Publication Details

Journal
OncoImmunology
Published
2026-11-14
DOI
https://doi.org/10.1080/2162402x.2026.2762243
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Timing-dependent dasatinib priming attenuates MHC class I-mediated inhibition of NK cells and CAR-NK cells

Mijeong Lee, Seoin Hwang, Jeehun Park, Byung Woo Han et al.
OncoImmunology
Immune Cell Function and Interaction
article

Timing-dependent dasatinib priming attenuates MHC class I-mediated inhibition of NK cells and CAR-NK cells

Mijeong Lee, Seoin Hwang, Jeehun Park, Byung Woo Han, Donghyeon Jo, Jinho Kim, Tung Nguyen Thanh Uong, Duck Cho, Junsang Doh, Nhat Phuoc Nguong Minh Nguyen, Yujung Jo, Seung-Hwan Lee, Hyun-Young Kim
article en

Abstract

Natural killer (NK) cells are promising candidates for adoptive immunotherapy, but their ex vivo expansion is often accompanied by reduced cellular fitness and functional heterogeneity. Here, we identified that dasatinib, an FDA-approved tyrosine kinase inhibitor, could improve the expansion and antitumor function of NK cells. While dasatinib treatment from the start of culture impaired NK cell expansion, the introduction of dasatinib after the early expansion phase improved NK cell yields and viability without compromising NK cell purity. Transcriptomic analysis showed that dasatinib priming suppressed inflammatory signaling pathways and reduced the expression of apoptosis-related genes. Both transcriptomic and phenotypic analyzes further demonstrated downregulation of inhibitory signaling components, including SHP-1 and killer cell immunoglobulin-like receptor (KIR) family members. In line with these molecular changes, dasatinib-primed NK cells displayed enhanced cytotoxicity against tumor cells expressing high levels of MHC class I, consistent with modulation of MHC class I-related inhibitory signaling. Moreover, dasatinib priming improved the antitumor activity of anti-CD19 CAR-NK cells and enhanced cytotoxicity against MHC class I-expressing CD19+ tumor cells. Collectively, these findings identify dasatinib priming as a simple and clinically applicable strategy to improve the function and antitumor efficacy of expanded NK cells and CAR-NK cells.

OncoImmunologyVol. 15(1)
Seoul National University (KR), University of Ottawa (CA), Kangwon National University (KR), University of Calgary (CA), Samsung Medical Center (KR), Chonnam National University Hwasun Hospital (KR), Sungkyunkwan University (KR)
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon